Return to Course LibraryCE InformationPrint Course MaterialsFacultyRegister Now

Release Date:
April 1, 2016


Expiration Date:
May 1, 2018

 

FACULTY

Gillian M. Newstead, MD, FACR
Director, Global Breast Imaging
University of Chicago
Chicago, IL

 

 

 

Equipment Requirements

PC: Win7/Win8, Pentium processor or faster, at least 2GB RAM, Internet Explorer version 10/11, Mozilla FireFox version 33.0.

MAC: OS version 10.8/10.9, Intel processor, at least 2GB RAM, Safari version 6.2, FireFox 33.0

Implementation of
Abbreviated Breast MRI Protocols


Recording of a live webinar presented on March 10, 2016

Target Audience
A certified one-hour live webinar for breast imaging physicians and radiologic technologists

 

 

 

Format: Archived Webinar
Credit: 1.0 AMA PRA Category 1
Credit: 1.0 ARRT Category A (accepted by ARMRIT)
Tuition:  none

Course Overview
Breast MRI (BMRI) has long been known for its high sensitivity and specificity for detecting breast cancer, but the full BMRI protocol is time-consuming and expensive, limiting its use to high-risk and second-look imaging. The development of abbreviated BMRI protocols is proving to be as effective as the standard protocol but requires much less scan and interpretation time, potentially making BMRI available to a broader patient population.

This lecture includes a discussion on patient indications, the abbreviated protocols now under development, and tips on how to manage patients and workflow in clinical practice.

Educational Objectives
At the conclusion of this activity, participants should be better able to:

  • Discuss the published clinical studies reporting the benefits of using an abbreviated breast MRI protocol

  • Implement abbreviated MRI protocols to shorten image acquisition and interpretation

  • Compare the quality of clinical case images using abbreviated BMRI protocols vs current standard protocols


ACCME Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and International Center for Postgraduate Medical Education. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

Physicians
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

SA-CME: This activity meets the criteria for self-assessment toward the purpose of fulfilling requirements in the American Board of Radiology (ABR) Maintenance of Certification Program.

The European Accreditation Council for CME (EACCME®)
The UEMS-EACCME® has mutual recognition agreements with the American Medical Association (AMA) for live events and e-learning materials. For more information go to http://www.uems.eu/uems-activities/accreditation/eaccme.

Radiologic Technologists
This program has been approved by the American Society of Radiologic Technologists (ASRT) for 1.0 hour of ARRT Category A continuing education credit.

How to Enroll and Participate
There is no fee or prerequisite for this program.

  • Click ENROLL NOW, then CONTINUE, CONFIRM ORDER, and ACCESS COURSE NOW.
  • Click the blue link. Complete the precourse survey, then click SUBMIT.
  • Once the precourse survey is submitted, click on the blue link again to view the course.
  • Click on PLAYBACK. To view the streaming video, you may have to download the WebEx Player.

Credit
Your online account with ICPME serves as a permanent record of credit certificates earned through www.icpme.us

  • Log-in to your account at www.icpme.us
  • View the entire one-hour session. The question-and-answer period at the end of the lecture is not required to receive credit.
  • At the conclusion of the lecture, close the WebEx Player window.
  • From the COURSE HOME page, click the tabs for POSTTEST and for EVALUATION.
  • A passing grade of at least 75% is required to receive credit. You may take the test up to three times.
  • Upon receipt of a passing grade, click the certificate tab to print a credit certificate.


Faculty
Gillian M. Newstead, MD, FACR

Dr. Newstead received her medical degree from the University of Edinburgh in Scotland and completed an internship at The Genesee Hospital in Rochester, New York. Residency was completed in radiology at Strong Memorial Hospital in Rochester and Temple University Hospital in Philadelphia. She is board certified in Radiology by the American College of Radiology.

Dr. Newstead is a member of numerous medical organizations including the American College of Radiology, the Radiological Society of North America, Association for Breast Cancer Control, and the Society for Breast Imaging. She has published more than 50 papers in journals including Radiology, American Journal of Roentgenology, and European Radiology. Dr. Newstead’s awards and honors include election to fellowship status by the American College of Radiology. She was voted as the “Attending of the Year” for excellence in teaching by the residents at the New York University Department of Radiology.

Dr. Newstead’s research interests lie in breast cancer screening and diagnosis and breast MRI. Her work has been supported by grants from the American Cancer Society and the National Cancer Institute.

Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy.  The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.

The faculty has reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Gillian M. Newstead, MD, FACR has received consulting fees from Bayer AG and Bracco Diagnostics; fees for non-CME/CE services from Bayer AG; and has ownership interest in Three Palm Software.

The following planners and managers have reported NO financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Trace Hutchison, PharmD                                   Victoria Phoenix, BS
Linda McLean, MS                                             Jan Schultz, RN, MSN, CCMEP
Samantha Mattiucci, PharmD, CCMEP              Judi Smelker-Mitchek, RN, BSN

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners.  Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Questions?
For questions regarding this program, please contact ICPME:
Email: information@icpmed.com
Phone: 607-257-5860 x10


Jointly Provided by

 

This activity is supported by an independent educational grant from Bayer Healthcare Pharmaceuticals.

 

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.